Created in 2000 (United States), REGADENOSON own
1125 sister brands
and 17478 competing brands.
REGADENOSON is owned by Pfizer Inc, listed on the stock exchange of New York
REGADENOSON belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.